Target intelligence / Profile preview

BCL2 associated athanogene 4 pseudogene (null)

Target
null
Molecular classification
Other (Pseudogene)
01

Overview

The BCL2 associated athanogene 4 pseudogene (ENSG00000255107) is a non-functional sequence in the human genome related to the BAG4 gene, also known as silencer of death domains (SODD). Unlike the functional BAG4 gene—which encodes a protein involved in apoptosis regulation, chaperone activity, and potentially in cancer progression—the pseudogene does not produce a functional protein and is not implicated as a therapeutic target or biomarker. BAG4 itself is involved in inhibiting apoptosis and regulating stress responses, but these functions do not apply to its pseudogene variant. The *functional* gene/protein of interest is "BCL2 associated athanogene 4 (BAG4, SODD)", which *is* implicated in apoptosis, cell proliferation, and cancer, but ENSG00000255107 specifically refers to a non-coding, non-target pseudogene. Pseudogenes like ENSG00000255107 do not encode active proteins, have no established drug interactions, and are not considered direct therapeutic targets.

Other names
BAG family molecular chaperone regulator 4 pseudogeneLOC100288097BCL2 associated athanogene 4 pseudogeneENSG00000255107

Beyond the preview

Go deeper on BCL2 associated athanogene 4 pseudogene (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BCL2 associated athanogene 4 pseudogene (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call